SARS-CoV-2 Antibody Response in Patients with Co-morbidities in Kashmir’s Ethnic Population: An Observational Cohort Study

Introduction: Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) infection risks in co-morbid patients are still unknown two years after the pandemic began. The prevalence of antibodies against SARS-CoV-2 infection is crucial for determining disease preventive and mitigation strategies. O...

Full description

Bibliographic Details
Main Authors: Aaliya Mohi-Ud-Din Azad, Naveed Nazir Shah, Haamid Bashir, Adnan Hamza, Khurshid Ahmad Dar, Mir Shahnawaz
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2022-09-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/16910/56230_CE(AD)_F[SH]_PF1(AG_KM)_PFA(AG_KM)_PN(KM).pdf